Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Durable Equipment Maker Reacts To Competitive Bidding Proposal

This article was originally published in The Gray Sheet

  • News

Executive Summary

One week after CMS released its competitive bidding proposal for durable medical equipment, a key industry stakeholder zeroed in on the need to narrowly define categories within HCPCS codes for bidding purposes

You may also be interested in...



Final Regulation Establishes Competitive Bidding For Durable Equipment

CMS will require certain medical supply manufacturers to begin submitting pricing bids to Medicare this month under a final 1regulation published April 2

Final Regulation Establishes Competitive Bidding For Durable Equipment

CMS will require certain medical supply manufacturers to begin submitting pricing bids to Medicare this month under a final 1regulation published April 2

DME Competitive Bidding Program Detailed In Proposed Medicare Regulation

Medicare will begin paying competitively bid prices for durable medical equipment in certain parts of the U.S. on Oct. 1, 2007, according to a proposed regulation

Table

View full table

Tags:
Latest Headlines

Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities

News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

See All
UsernamePublicRestriction

Register

MT023519

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By